Research and development - Press Releases

Date	Title	Company
27-Aug-2021	Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer.	Clinerion Ltd.
27-Aug-2021	CD Formulation Announces Ability to Develop Liquid Dosage Forms	CD Formulation
23-Aug-2021	Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in Motor and Non-Motor Functions in Children with AADC Deficiency	PTC Therapeutics, Inc.
23-Aug-2021	Birmingham scientists discover new piece of clotting puzzle	University of Birmingham Enterprise Ltd
22-Aug-2021	Anatara’s IBS-D clinical trial to leverage Microba Life Sciences’ precision microbiome analysis	Microba Life Sciences
20-Aug-2021	Almac Group and PILA PHARMA Ink Manufacturing Agreement	Almac
20-Aug-2021	Clinerion patent for technology underpinning Patient Network Explorer is published.	Clinerion Ltd.
20-Aug-2021	Human Bone Marrow-derived Mononuclear Cells and Their Applications	AcceGen
18-Aug-2021	Stream Sensing offers in-line, real-time rheology measurement in processing industry first	Stream Sensing
17-Aug-2021	Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis	Mundipharma
16-Aug-2021	Birmingham researchers confirm speed, simplicity and sensitivity for new COVID-19 test	University of Birmingham Enterprise Ltd
12-Aug-2021	Biotium launches optimized solution for exosome detection by flow cytometry	Biotium
11-Aug-2021	PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features	Janssen
09-Aug-2021	SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS TREMFYA®▼ (GUSELKUMAB), THE FIRST IL-23 p19 INHIBITOR TREATMENT, FOR ACTIVE PSORIATIC ARTHRITIS (PsA)	Janssen
06-Aug-2021	CD BioSciences Launches ISS and ISE Study Design Services for Clinical Trials	CD BioSciences
06-Aug-2021	CD Bioparticles Launches Cleavable Linkers to Accelerate Customer Research	CD Bioparticles
06-Aug-2021	STEMart Introduces Medical Device Hemocompatibility Testing Service	STEMart
06-Aug-2021	Creative Diagnostics Launches Pseudotyped VSV-SARS-CoV-2 Spike for Research Use	Creative Diagnostics
06-Aug-2021	Adsorptive Polymers Are Now Available at Alfa Chemistry	Alfa Chemistry
06-Aug-2021	Alfa Chemistry Catalysts Announces to Provide Oxazole Ligands, Oxazoline Ligands and Thiazole Ligands for Scientific Research	Alfa Chemistry Catalysts